In Alzheimer disease (AD)–Salivary AChE activity may prove to be a useful marker of AD–associated changesin central cholinergic activity and the responsiveness of patients to treatment with AChE inhibitors [1]. The gene discussed is ACHE; the disease is Alzheimer disease.